Farcast Biosciences

Development of the Human Tumor Microdynamics (HTMD) Platform for the Treatment of Human Tumors. The company's platform generates and mines Tumor Microdynamics (TMD) response data for high-fidelity, multi-modal, human-relevant translational evidence and insights. Utilizing freshly cultured human tumors and autologous blood samples in systems that maintain the tumor microenvironment close to its native state, it enables precise therapeutic and diagnostic development, producing accurate biomarkers to predict each tumor’s response. This allows physicians to generate biosignatures based on multiple simultaneous treatment test conditions for each patient’s tumor.